A study published in the New England Journal of Medicine shows that suPAR protein (soluble urokinase-type plasminogen activator receptor) is a promising marker of chronic kidney disease risk. Circulating protein can be measured in a blood sample. High level of suPAR can indicate the likelihood of developing chronic kidney disease up to five years before kidney damage will begin.
An interdisciplinary group of scientists from Boston University School of Medicine has described a new protein named TMIGD1 that proved to be engaged into epithelial cells protection in the renal tubules. This particular protein in the future could become a target of new therapeutic strategies used in patients suffering from both acute and chronic kidney disease. Read full text »